companies

MyPL

Founded 2017
Employees 15+
Primary contact
12 avenue des Près
78180 Montigny le Bretonneux
Île-de-France
France
+33645460669
Links
https://mypl.io/
Diseases & Conditions
Sections
Technologies
MyPL has developed a personalized augmented medicine platform built on a global approach to patient data, which helps healthcare professionals to determine the personalized therapeutic strategies accurately to be implemented for a given patient, particularly in the case of cancer patients. This unique data visualization solution allows a large amount of data as well as the patient profile to be centralized on a smart dashboard. On the other hand, the platform enables physicians to get an exhaustive, unique, and relevant clinical view of each case. In addition, the company also offers a service that allows the monitoring of clinical trials related to all cancer types and rare disorders.
Founded 2017
Employees 15+
Primary contact
12 avenue des Près
78180 Montigny le Bretonneux
Île-de-France
France
+33645460669
Links
https://mypl.io/
Diseases & Conditions
Sections
Technologies

Funding 💰

Total €1.8M
Select investors Karista

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • MyPL MTC: The company's solution for Multidiscipline Treatment Conferences (also known as Tumor Board Meetings). It generates highly visual and holistic patient profiles, including more than 150 structured & clinically qualified data inputs. MyPL MTC is a Medical Device (MD) bearing the CE marking. 🔗
  • MyPL My Care Journey: A patient-centric digital solution developed with the ambition of reducing the burden of cancer treatments and all its many processes for patients. It gives them a complete view of their care pathway and immediate access to some of their clinical information, while opening communication with their medical team and caregivers. 🔗
  • MyPL Analytics: The solution that offers a transformative way of conducting, monitoring and assessing clinical trials. It draws meaningful insights from an exhaustive clinical trial database and gives access to proven clinical data. 🔗
  • Already in use: MyPL is set to have its solutions deployed in 50 major cancer centers and hospitals, conducting observational and clinical studies.

Video ▶️

Quotes 💬

“
We are very pleased to be supporting MyPL in its first crucial stages of deployment in hospitals. We are convinced that the strategic positioning of this smart data centralisation and visualisation platform provides a vital and differentiating solution to facilitate TCMs. The value of this platform is indisputable for physicians, pharmaceutical companies and cancer patients alike. MyPL is a perfect example of what digital health can offer in concrete terms today, based on cutting-edge technologies such as Artificial Intelligence and the secure health data management.
— Catherine Boule, Managing Partner of Karista 🔗
Last update: January 13, 2023